18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores

18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores

Background18F-FDG-PET/CT may reveal widespread inflammation of musculoskeletal structures in polymyalgia rheumatica (PMR). Currently, scans are subjectively analysed based on the overall gestalt of the scan. Standardized PET scores may potentially aid the interpretation of the scans for suspected PM...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kornelis S. M. van der Geest, Rob G. J. Grootelaar, Karin Bouwman, Maria Sandovici, Andor W. J. M. Glaudemans, Elisabeth Brouwer, Riemer H. J. A. Slart
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Nuclear Medicine
Subjects:	FDG-PET/CT polymyalgia rheumatica scores scan report treatment sensitivity
Online Access:	https://www.frontiersin.org/articles/10.3389/fnume.2025.1550881/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica
by: Andreas Wiggers Nielsen, et al.
Published: (2025-04-01)

POLYMYALGIA RHEUMATICA
by: A. M. Satybaldyev, et al.
Published: (2018-05-01)

REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF POLYMYALGIA RHEUMATICA (ACR/EULAR 2015)
by: M. T. Vatutin, et al.
Published: (2016-03-01)

Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports
by: Ciro Manzo, et al.
Published: (2025-04-01)

The evolution of diagnosis of polymyalgia rheumatica
by: A. M. Satybaldyev
Published: (2019-12-01)

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?
by: Ciro Manzo, et al.
Published: (2025-03-01)

Experience with olokizumab in the treatment of polymyalgia rheumatica and giant cell arteritis: A series of cases
by: Alexey D. Meshkov, et al.
Published: (2024-09-01)

Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway
by: Stig Tengesdal, et al.
Published: (2025-07-01)

Relapses of pain syndrome in patients with polymyalgia rheumatica during reduction of glucocorticoid therapy
by: N. V. Bunchuk
Published: (2023-02-01)

Polymyalgia rheumatica - risk factors, pathogenesis, diagnostic methods, treatment - new literature reports
by: Anita Warzocha, et al.
Published: (2025-07-01)

Association of SSRI and SNRI use with incidence of cardiovascular events in veterans with giant cell arteritis and polymyalgia rheumatica
by: Tianyu Zhang, et al.
Published: (2025-04-01)

Development and evaluation of disease-specific patient-reported outcome measures questionnaire for polymyalgia rheumatica: validity, reliability, and responsiveness
by: Yasser El Miedany, et al.
Published: (2025-04-01)

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
by: Evgeny L. Nasonov, et al.
Published: (2024-09-01)

Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases
by: D. Camellino, et al.
Published: (2024-10-01)

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
by: Pierre-André Jarrot, et al.
Published: (2024-12-01)

18F-fluorodeoxyglucose positron emission tomography/ computed tomography of giant cell arteritis with lower extremity involvement in association with polymyalgia rheumatica
by: Ananya Panda, et al.
Published: (2021-03-01)

Damage to extracranial arteries in giant cell arteritis according to PET/CT
by: E. E. Filatova, et al.
Published: (2023-03-01)

A Case of PMR‐Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung Cancer
by: Ryuichi Utsumi, et al.
Published: (2025-06-01)

The Use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
by: Andor W. J. M. Glaudemans, et al.
Published: (2013-01-01)

A Machine Learning Model Based on Radiomic Features as a Tool to Identify Active Giant Cell Arteritis on [<sup>18</sup>F]FDG-PET Images During Follow-Up
by: Hanne S. Vries, et al.
Published: (2025-02-01)

Large-vessel giant cell arteritis: A rare cause of stroke
by: Himanshu Pathak, et al.
Published: (2017-01-01)

Recent Updates of PET in Lymphoma: FDG and Beyond
by: Sung-Yong Kim, et al.
Published: (2024-10-01)

CURRENT VIEW OF HORTON'S DISEASE: ANALYSIS OF ITS CASES IN THE KHABAROVSK TERRITORY
by: E. N. Otteva, et al.
Published: (2011-06-01)

Clinical manifestations and prognosis of giant cell arteritis: A retrospective cohort study
by: E. E. Filatova, et al.
Published: (2024-01-01)

FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS
by: Ellen Nogueira Lima, et al.
Published: (2025-05-01)

Radiomics with Clinical Data and [<sup>18</sup>F]FDG-PET for Differentiating Between Infected and Non-Infected Intracavitary Vascular (Endo)Grafts: A Proof-of-Concept Study
by: Gijs D. van Praagh, et al.
Published: (2025-08-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
by: SALONI RAJKOTIA, et al.
Published: (2024-11-01)

FDG-PET/BT ile tespit edilen küçük hücreli akciğer kanserinin kemik iliği metastazı
by: Mustafa Serdengeçti, et al.
Published: (2015-09-01)

Dedifferentiated liposarcoma lung metastases with different FDG-PET/CT findings
by: Yoshito Imamura, et al.
Published: (2023-05-01)

Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
by: Yousif A. Lucinian, et al.
Published: (2022-12-01)

[18F]-FDG PET-CT in Malignant Melanoma
by: Teodora Sidonia Mititelu, et al.
Published: (2025-05-01)

Utility of FDG PET/CT in Sjögren’s Syndrome and associated lymphomas; Lymphomagenesis
by: Dikhra Khan, et al.
Published: (2025-01-01)

[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
by: Dandan Yu, et al.
Published: (2025-01-01)

Clinical picture of polymialgia rheumatica in Habarovsk region’s residents
by: T. Y. Kocherova,, et al.
Published: (2016-05-01)

AUTOIMMUNE ENCEPHALITIS AND PARANEOPLASTIC SYNDROMES: A CLINICAL AND FDG-PET/CT STUDY
by: Maurício Martins Baldissin, et al.
Published: (2025-05-01)

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer
by: Matthew J. Roberts, et al.
Published: (2025-07-01)

18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
by: Teik Hin Tan, et al.
Published: (2022-06-01)

Correlation of bisphenol A and bisphenol S exposure with the metabolic parameters on FDG PET/CT image
by: Liu Xiao, et al.
Published: (2024-11-01)

Hipometabolismo cerebral em pacientes com esclerose mesial temporal demonstrado pelo FDG-PET
by: PAULO S. DUARTE, et al.
Published: (2000-09-01)